Study depression treatment effects in people living with HIV
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study looks at how depression and its treatment may affect the brain and immune-related body systems in people with HIV. You may be eligible if you have depression and a well-controlled HIV viral load, and you can safely complete brain MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can read and speak English
- You have HIV and are taking HIV medications under your own name
- You currently have major depression (by a structured interview or depression score 7+)
- If you take antidepressants, your dose has been the same for at least 2 months
- Your HIV viral load is under 200 copies/mL and you can safely have an MRI scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This Phase 2 study looks at whether lowering inflammation can help improve depression symptoms in adults living with HIV. You may be able to join if your HIV is well controlled and you are currently experiencing major depression (or a certain type of bipolar depression).
This study uses brain scans to understand how stimulant use affects the brain in people with HIV who are on treatment. It may help find ways to improve brain health.
This study looks at the mental health and emotional well-being of people living with HIV. It aims to understand how they are feeling so that better support can be provided.
This trial studies how the HIV drug dolutegravir works in people who also have depression. Participants will receive an antidepressant called fluoxetine to see how it affects the HIV treatment.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.